Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.

Matasar MJ, Luminari S, Barr PM, Barta SK, Danilov AV, Hill BT, Phillips TJ, Jerkeman M, Magagnoli M, Nastoupil LJ, Persky DO, Okosun J.

Oncologist. 2019 Jul 25. pii: theoncologist.2019-0138. doi: 10.1634/theoncologist.2019-0138. [Epub ahead of print] Review.

PMID:
31346132
2.

Physical Exercise in Major Depression: Reducing the Mortality Gap While Improving Clinical Outcomes.

Belvederi Murri M, Ekkekakis P, Magagnoli M, Zampogna D, Cattedra S, Capobianco L, Serafini G, Calcagno P, Zanetidou S, Amore M.

Front Psychiatry. 2019 Jan 10;9:762. doi: 10.3389/fpsyt.2018.00762. eCollection 2018.

3.

Tabagism and its management in Italian Psychiatric Intensive Care General Hospital Units

Corsini G, Trabucco A, Respino M, Magagnoli M, Spiridigliozzi D, Escelsior A, Amore M.

Riv Psichiatr. 2018 Nov-Dec;53(6):309-316. doi: 10.1708/3084.30764. Italian.

PMID:
30667397
4.

FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.

Fracchiolla NS, Artuso S, Cortelezzi A, Pelizzari AM, Tozzi P, Bonfichi M, Bocchio F, Gargantini L, De Rosa E, Vighi GD, Prestini L, Sammassimo S, Frungillo N, Pasquini MC, Ragazzi A, Boghi D, Pastore A, Lanzi E, Gritti G, Quaresmini G, Voltolini S, Gaiardoni R, Corti C, Vilardo MC, La Targia ML, Berini G, Magagnoli M, Bacci C, Consonni D, Rivolta AL, Muti G.

Hematol Oncol. 2018 Feb;36(1):299-306. doi: 10.1002/hon.2451. Epub 2017 Aug 3.

PMID:
28771763
5.

Physical Exercise for Late-Life Depression: Customizing an Intervention for Primary Care.

Zanetidou S, Belvederi Murri M, Menchetti M, Toni G, Asioli F, Bagnoli L, Zocchi D, Siena M, Assirelli B, Luciano C, Masotti M, Spezia C, Magagnoli M, Neri M, Amore M, Bertakis KD; Safety Efficacy of Exercise for Depression in Seniors Study Group.

J Am Geriatr Soc. 2017 Feb;65(2):348-355. doi: 10.1111/jgs.14525. Epub 2016 Nov 21.

PMID:
27869986
6.

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).

Balzarotti M, Brusamolino E, Angelucci E, Carella AM, Vitolo U, Russo E, Congiu A, Gotti M, Massidda S, Botto B, Annechini G, Spina M, Re A, Zilioli VR, Merli F, Salvi F, Stelitano C, Bonfichi M, Rodari M, Murru R, Magagnoli M, Anastasia A, Mazza R, Giordano L, Santoro A.

Leuk Lymphoma. 2016 Oct;57(10):2375-81. doi: 10.3109/10428194.2016.1140161. Epub 2016 Feb 15.

PMID:
26879066
7.

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Castagna L, Crocchiolo R, Giordano L, Bramanti S, Carlo-Stella C, Sarina B, Chiti A, Mauro E, Gandolfi S, Todisco E, Balzarotti M, Anastasia A, Magagnoli M, Brusamolino E, Santoro A.

Bone Marrow Transplant. 2015 Apr;50(4):499-504. doi: 10.1038/bmt.2014.304. Epub 2015 Jan 26.

PMID:
25621797
8.

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group.

Conconi A, Raderer M, Franceschetti S, Devizzi L, Ferreri AJ, Magagnoli M, Arcaini L, Zinzani PL, Martinelli G, Vitolo U, Kiesewetter B, Porro E, Stathis A, Gaidano G, Cavalli F, Zucca E.

Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

PMID:
24673512
9.

Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma.

Spina M, Balzarotti M, Uziel L, Ferreri AJ, Fratino L, Magagnoli M, Talamini R, Giacalone A, Ravaioli E, Chimienti E, Berretta M, Lleshi A, Santoro A, Tirelli U.

Oncologist. 2012;17(6):838-46. doi: 10.1634/theoncologist.2011-0417. Epub 2012 May 18.

10.

Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies.

Saber W, Moua T, Williams EC, Verso M, Agnelli G, Couban S, Young A, De Cicco M, Biffi R, van Rooden CJ, Huisman MV, Fagnani D, Cimminiello C, Moia M, Magagnoli M, Povoski SP, Malak SF, Lee AY.

J Thromb Haemost. 2011 Feb;9(2):312-9. doi: 10.1111/j.1538-7836.2010.04126.x.

11.

Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.

Castagna L, Bramanti S, Balzarotti M, Sarina B, Todisco E, Anastasia A, Magagnoli M, Mazza R, Nozza A, Giordano L, Rodari M, Rinifilo E, Chiti A, Santoro A.

Br J Haematol. 2009 May;145(3):369-72. doi: 10.1111/j.1365-2141.2009.07645.x. Epub 2009 Mar 5.

PMID:
19344403
12.

Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma.

Castagna L, Sarina B, Todisco E, Magagnoli M, Balzarotti M, Bramanti S, Mazza R, Anastasia A, Bacigalupo A, Aversa F, Soligo D, Giordano L, Santoro A.

Biol Blood Marrow Transplant. 2009 Apr;15(4):432-8. doi: 10.1016/j.bbmt.2008.12.506. Epub 2009 Feb 12.

13.

What is the best option to cure patients with resistant/relapsing Hodgkin's disease?

Magagnoli M, Balzarotti M, Castagna L, Demarco M, Santoro A.

Curr Stem Cell Res Ther. 2006 Sep;1(3):419-24. Review.

PMID:
18220885
14.

High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.

Magagnoli M, Balzarotti M, Siracusano LV, Spina M, Isa L, Morenghi E, Tirelli U, Santoro A.

Leuk Lymphoma. 2007 Dec;48(12):2444-6. Epub 2007 Oct 9. No abstract available.

PMID:
17943600
15.

IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patients.

Magagnoli M, Spina M, Balzarotti M, Timofeeva I, Isa L, Michieli M, Capizzuto R, Morenghi E, Castagna L, Tirelli U, Santoro A.

Bone Marrow Transplant. 2007 Dec;40(11):1019-25. Epub 2007 Oct 1.

PMID:
17906705
16.

Herpes infections in breast cancer patients treated with adjuvant chemotherapy.

Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A.

Oncology. 2006;71(3-4):164-7. Epub 2007 Jul 18.

PMID:
17641534
17.

Focal extra-axial hemorrahagic mass with subdural hemorrhage secondare to extramedullary hematopoiesis in idiopathic myelodysplastic sindrome.

Di Ieva A, Aimar E, Tancioni F, Levi D, Debernardi A, Pisano P, Rahal D, Nozza A, Magagnoli M, Gaetani P.

J Neurosurg Sci. 2007 Mar;51(1):29-32. Erratum in: J Neurosurg Sci. 2007 Sep;51(3):152. Di Lieva, A [corrected to Di Ieva, A].

PMID:
17369789
18.

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.

Todisco E, Castagna L, Sarina B, Mazza R, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Anastasia A, Demarco M, Santoro A.

Eur J Haematol. 2007 Feb;78(2):111-6.

PMID:
17313558
19.

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma.

Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, Nozza A, Sarina B, Morenghi E, Castagna L, Tirelli U, Balzarotti M.

Haematologica. 2007 Jan;92(1):35-41.

20.

Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

Castagna L, Magagnoli M, Balzarotti M, Sarina B, Siracusano L, Nozza A, Todisco E, Bramanti S, Mazza R, Russo F, Timofeeva I, Santoro A.

Am J Hematol. 2007 Feb;82(2):122-7.

21.

Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications.

Masci G, Magagnoli M, Pedicini V, Poretti D, Castagna L, Carnaghi C, Morenghi E, Del Vecchio A, Finotto R, Brambilla G, Santoro A.

Support Care Cancer. 2006 Nov;14(11):1141-6. Epub 2006 Apr 19.

PMID:
16622649
23.

Lymphomas.

Santoro A, Castagna L, Magagnoli M.

Cancer Chemother Biol Response Modif. 2005;22:391-9. Review. No abstract available.

PMID:
16110621
24.

High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens.

Magagnoli M, Masci G, Castagna L, Morenghi E, Santoro A.

Ann Oncol. 2006 Jan;17(1):174-6. Epub 2005 Aug 12. No abstract available.

PMID:
16100233
25.

Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.

Magagnoli M, Masci G, Castagna L, Zucali PA, Morenghi E, Pedicini V, Santoro A.

Anticancer Res. 2005 Jul-Aug;25(4):3143-7.

26.

High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin.

Magagnoli M, Masci G, Castagna L, Bramanti S, Morenghi E, Carnaghi C, Santoro A.

Br J Haematol. 2005 Jun;129(5):709-10. No abstract available.

PMID:
15916696
27.

Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy.

Siracusano L, Balzarotti M, Magagnoli M, Castagna L, Rahal D, Santoro A.

Am J Hematol. 2005 Apr;78(4):312-3.

28.

Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

Magagnoli M, Castagna L, Masci G, Santoro A.

Oncologist. 2004;9(5):594-5; author reply 596. No abstract available.

29.

Lymphomas.

Santoro A, Castagna L, Magagnoli M.

Cancer Chemother Biol Response Modif. 2003;21:399-428. Review. No abstract available.

PMID:
15338757
30.

Metastasis of hepatocellular carcinoma to the heart: a case report and review of the literature.

Masci G, Magagnoli M, Grimaldi A, Covini G, Carnaghi C, Rimassa L, Santoro A.

Tumori. 2004 May-Jun;90(3):345-7. Review.

PMID:
15315319
31.

Solitary plasmacytoma of the duodenum.

Magagnoli M, Pedicini V, Rahal D, Santoro A.

Am J Hematol. 2004 Jun;76(2):185-6. No abstract available.

32.

Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen.

Magagnoli M, Castagna L, Bramanti S, Balzarotti M, Santoro A.

Bone Marrow Transplant. 2004 May;33(10):1067-8. No abstract available.

PMID:
15129236
33.

Intermediate-dose melphalan with stem-cell support in platinum-refractory ovarian cancer.

Magagnoli M, Masci G, Castagna L, Rimassa L, Bramanti S, Santoro A.

Bone Marrow Transplant. 2004 Jun;33(12):1261-2. No abstract available.

PMID:
15107813
34.

Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?

Magagnoli M, Balzarotti M, Castagna L, Rahal D, Siracusano L, Nozza A, Santoro A.

Leuk Lymphoma. 2003 Sep;44(9):1639-40. No abstract available.

PMID:
14565674
35.

Prospective study of high-dose chemotherapy and autologous peripheral stem cell transplantation in adult patients with advanced desmoplastic small round-cell tumour.

Bertuzzi A, Castagna L, Quagliuolo V, Ginanni V, Compasso S, Magagnoli M, Balzarotti M, Nozza A, Siracusano L, Timofeeva I, Sarina B, Parra HS, Santoro A.

Br J Cancer. 2003 Oct 6;89(7):1159-61.

36.

High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysis.

Magagnoli M, Castagna L, Timofeeva I, Balzarotti M, Santoro A.

Leuk Lymphoma. 2003 Aug;44(8):1439-40. No abstract available.

PMID:
12952242
37.

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.

Magagnoli M, Castagna L, Balzarotti M, Sarina B, Timofeeva I, Bertuzzi A, Compasso S, Nozza A, Siracusano L, Santoro A.

Am J Hematol. 2003 Aug;73(4):267-72.

38.

Early restaging positron emission tomography with 18F-fluorodeoxyglucose in aggressive non-Hodgkin's lymphomas: is it too easy to be true?

Balzarotti M, Magagnoli M, Santoro A.

Ann Oncol. 2003 Jul;14(7):1155-6. No abstract available.

PMID:
12853364
39.

Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.

Magagnoli M, Masci G, Carnaghi C, Zucali PA, Castagna L, Morenghi E, Santoro A.

Ann Oncol. 2003 Jun;14(6):959-60. No abstract available.

PMID:
12796035
40.

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

Masci G, Magagnoli M, Zucali PA, Castagna L, Carnaghi C, Sarina B, Pedicini V, Fallini M, Santoro A.

J Clin Oncol. 2003 Feb 15;21(4):736-9.

PMID:
12586814
41.

Cardiac involvement in non-Hodgkin's lymphoma.

Magagnoli M, Nozza A, Romano Lutman F, Santoro A.

Br J Haematol. 2002 Dec;119(4):887. No abstract available.

PMID:
12472562
42.

Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas.

Castagna L, Bertuzzi A, Nozza A, Siracusano L, Balzarotti M, Magagnoli M, Sarina B, Timofeeva I, Sinnone M, Grimoldi MG, Farè M, Santoro A.

Bone Marrow Transplant. 2002 Aug;30(4):207-14.

43.

Intensified CHOP regimen in aggressive lymphomas: maximal dose intensity and dose density of doxorubicin and cyclophosphamide.

Balzarotti M, Spina M, Sarina B, Magagnoli M, Castagna L, Milan I, Ripa C, Latteri F, Bernardi D, Bertuzzi A, Nozza A, Roncalli M, Morenghi E, Tirelli U, Santoro A.

Ann Oncol. 2002 Sep;13(9):1341-6.

PMID:
12196358
44.

Combined systemic and intrathecal chemotherapy plus radiotherapy in testicular lymphoma: a report of two cases.

Magagnoli M, Balzarotti M, Castagna L, Bertuzzi A, Nozza A, Santoro A.

Haematologica. 2002 Apr;87(4):ELT22. No abstract available.

PMID:
11940507
45.

Isolated massive meningeal progression in aggressive non Hodgkin's lymphoma.

Magagnoli M, Nozza A, Santoro A.

Haematologica. 2002 Apr;87(4):EIM15. No abstract available.

PMID:
11940503
46.

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma.

Magagnoli M, Sarina B, Balzarotti M, Castagna L, Timofeeva I, Nozza A, Bertuzzi A, Siracusano L, Sinnone M, Santoro A.

Bone Marrow Transplant. 2001 Nov;28(10):923-7.

47.

Comparison of prognostic models in patients with advanced Hodgkin disease. Promising results from integration of the best three systems.

Gobbi PG, Zinzani PL, Broglia C, Comelli M, Magagnoli M, Federico M, Merli F, Iannitto E, Tura S, Ascari E.

Cancer. 2001 Apr 15;91(8):1467-78.

PMID:
11301394
48.

Allogeneic stem cell transplantation and non-myeloablative conditioning regimens.

Castagna L, Bertuzzi A, Nozza A, Siracusano L, Balzarotti M, Magagnoli M, Sarina B, Santoro A.

Tumori. 2000 Sep-Oct;86(5 Suppl 2):S38-42. Review. No abstract available.

PMID:
11195302
49.

Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia.

Zinzani PL, Bendandi M, Magagnoli M, Albertini P, Rondelli D, Stefoni V, Tani M, Tura S.

Haematologica. 2000 Nov;85(11):1135-9.

50.

Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.

Zinzani PL, Magagnoli M, Bendandi M, Tani M, Stefoni V, Cellini C, Poggi S, Piccioli M, Pileri S, Tura S.

Haematologica. 2000 Sep;85(9):922-5.

Supplemental Content

Loading ...
Support Center